Abstract:Background Hepatic caveolin-1 (CAV1) is reduced in cholesterol gallstone disease (CGD). Mice with CAV1 deficiency were prone to develop CGD. However, it remains unknown whether restored hepatic CAV1 expression prevents the development of CGD. Methods C57BL/6 mice were injected with adeno-associated virus 2/8 (AAV2/8) vectors carrying the CAV1 gene ((AAV2/8)CAV1) via intravenous (i.v.) or intraperitoneal (i.p.) route and then subjected to a lithogenic diet (LD) for 8 weeks. Uninjected mice were used as controls. The functional consequences of rescuing CAV1 expression by either i.v. or i.p. (AAV2/8)CAV1 treatment for CGD prevention and its subsequent molecular mechanisms were examined. Results CAV1 expression was reduced in the liver and gallbladder of LD-fed CGD mice. We discovered that (AAV2/8)CAV1 i.p. delivery results in higher transduction efficiency in the gallbladder than tail vein administration. Although either i.v. or i.p. injection of (AAV2/8)CAV1 improved liver lipid metabolic abnormalities in CGD mice but did not affect LD feeding-induced bile cholesterol supersaturation. In comparison with i.v. administration route, i.p. administration of (AAV2/8)CAV1 obviously increased CAV1 protein levels in the gallbladder of LD-fed mice, and i.p. delivery of (AAV2/8)CAV1 partially improved gallbladder cholecystokinin receptor (CCKAR) responsiveness and impeded bile cholesterol nucleation via the activation of adenosine monophosphate-activated protein kinase (AMPK) signaling, which induced a reduction in gallbladder mucin-1 (MUC1) and MUC5ac expression and gallbladder cholesterol accumulation. Conclusion CGD prevention by i.p. (AAV2/8)CAV1 injection in LD-fed mice was associated with the improvement of gallbladder stasis, which again supported the notion that supersaturated bile is required but not sufficient for the formation of cholesterol gallstones. Additionally, AAV treatment via the local i.p. injection offers particular advantages over the systemic i.v. route for much more effective gallbladder gene delivery, which will be an excellent tool for conducting preclinical functional studies on the maintenance of normal gallbladder function to prevent CGD.

Effects of Azintamide for Guinea Pig with Cholesterol Gallstone

Experimental study on Shu Dan Tong granules in prevention and frecatment effects of cholelithiasis

Effect of Hepatic NPC1L1 on Cholesterol Gallstone Disease and Its Mechanism

The Effect of Shudantong Granules on Animals’ Bile Secretion and Gallbladder Smooth Muscle

Pioglitazone prevents cholesterol gallstone formation through the regulation of cholesterol homeostasis in guinea pigs with a lithogenic diet

Adeno-associated Virus-Based Caveolin-1 Delivery Via Different Routes for the Prevention of Cholesterol Gallstone Formation

Expression and Its Significance of Caveolin–1 in Liver and Gallbladder of Gallstone Mice Model

Differences Between Hepatic and Biliary Lipid Metabolism and Secretion in Genetically Gallstone-Susceptible and Gallstone-Resistant Mice

Can Pigment Gallstones Be Induced by Biliary Stricture and Prevented by Medicine in Guinea Pigs

The Ability of Bile to Scavenge Superoxide Radicals and Pigment Gallstone Formation in Guinea Pigs

Ursodeoxycholic Acid Protects Interstitial Cajal-like Cells in the Gallbladder from Undergoing Apoptosis by Inhibiting TNF-α Expression

Effects of Sphincter of Oddi Motility on the Formation of Cholesterol Gallstones.

Prevention of Gallstones by Lidan Granule: Insight into Underlying Mechanisms Using a Guinea Pig Model

Effects of Ursodeoxycholic Acid on Intrahepatic Cholestasis in Rats

Astragalus Polysaccharides Ameliorate Diet-Induced Gallstone Formation by Modulating Synthesis of Bile Acids and the Gut Microbiota

C-Kit expression in the gallbladder of guinea pig with chronic calculous cholecystitis and the effect of Artemisia capillaris Thunb on interstitial cells of Cajal

Effect of nicotine on cholesterol gallstone formation in C57BL/6J mice fed on a lithogenic diet

Role of Baicalin and Liver X Receptor Alpha in the Formation of Cholesterol Gallstones in Mice

Aqueous Extract of Lysimachia christinae Hance Prevents Cholesterol Gallstone in Mice by Affecting the Intestinal Microflora

Inhibiting miRNA-146a suppresses mouse gallstone formation by regulating LXR/megalin/cubilin-media cholesterol absorption

The effect of ursodeoxycholic acid on the relative expression of the lipid metabolism genes in mouse cholesterol gallstone models